Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2024-04-28 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
2023年半年度报告（更正公告）
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial disclosure containing corrected financial data for multiple periods including 2021, 2022, and 2023 quarters and half-year. It includes corrected revenue, profit, cost, and other financial metrics, as well as detailed segment and regional analysis. The document references accounting standards and correction of prior accounting errors, and provides comprehensive financial tables such as consolidated profit statements. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or certification. This matches the characteristics of an Interim / Quarterly Report (IR), as it covers a period shorter than a full fiscal year with substantive financial data and analysis. It is not a full Annual Report (10-K) since it focuses on interim periods and corrections. Therefore, the appropriate classification is IR with high confidence. H1 2023
2024-04-28 Chinese
2023年半年度报告（更正后）
Interim / Quarterly Report Classification · 100% confidence The document is titled "半年度报告 2023" which translates to "Half-Year Report 2023". It contains detailed financial data including income, profit, assets, liabilities, and operational analysis for the period January 1, 2023 to June 30, 2023. The document includes sections such as company overview, accounting data, business overview, financial statements, and risk disclosures. It explicitly states it is a half-year report (interim report) and contains substantive financial data and analysis, not just an announcement or summary. The length is substantial (15,000 characters), and it is not a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2024-04-28 Chinese
关于变更定期公告披露时间的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement from Guangdong Drive Biological Technology Group Co., Ltd. stating a delay in the disclosure of their 2023 Annual Report and 2024 First Quarter Report. It mentions the original and new disclosure dates and apologizes for the inconvenience. The document does not contain the actual reports or financial data but only announces the postponement of their publication. According to the 'MENU VS MEAL' rule, such a short notice about report publication timing is classified as a Report Publication Announcement (RPA).
2024-04-25 Chinese
广东驱动力生物科技集团股份有限公司关于变更2023年年度报告预约披露时间的公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Guangdong Drive Biological Technology Group Co., Ltd. stating that the disclosure date of the 2023 annual report has been postponed from April 23, 2024, to April 26, 2024. It explicitly mentions the annual report but does not contain the report itself or any financial data. The document length is only 531 characters, indicating it is a brief notice rather than a full report. According to the 'Menu vs Meal' rule, this is a report publication announcement rather than the annual report itself.
2024-04-17 Chinese
2023年年度业绩预告公告
Earnings Release Classification · 95% confidence The document is a 2023 annual performance forecast announcement from Guangdong Drive Biological Technology Group Co., Ltd. It provides preliminary financial data for the full year 2023, including expected net profit and reasons for profit decline. It explicitly states that the data is preliminary, unaudited, and subject to change in the final 2023 annual report. The document is short (878 characters) and serves as a performance forecast rather than a full annual report or audited financial statement. It is an announcement of expected financial results, not the actual report itself. Therefore, it fits best as an Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only. FY 2023
2024-02-25 Chinese
高级管理人员任免公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment and resignation of senior management personnel, specifically the resignation of the former Vice General Manager and Board Secretary and the appointment of a new Vice General Manager and Board Secretary. It includes details about the qualifications, legal compliance, and the impact of these changes on the company's governance structure. There are no financial statements, earnings data, or regulatory filings related to financial performance. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2024-02-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.